Neximmune

Neximmune EBIT per Employee

The EBIT per Employee of Neximmune (NEXI) as of Oct 19, 2026 is -1.26 M USD. In the previous year, EBIT per Employee was -1.07 M USD — a change of 18.46% (lower).

EBIT per Employee

-1.26 MUSD

YoY

18.46%

Last updated:

EBIT per Employee of Neximmune is 2022 -1.26 M USD. EBIT per Employee of Neximmune was 2021 -1.07 M USD. It decreases by 18.46% lower compared to the previous year.

The Neximmune EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
-264,800.00 USD
Jan 1, 2019
-417,800.00 USD
Jan 1, 2020
-557,000.00 USD
Jan 1, 2021
-1.07 M USD
Jan 1, 2022
-1.26 M USD
The Neximmune EBIT per Employee history
YEAREBIT per EmployeeYoY
-1.26 MUSD+18.46%
-1.07 MUSD+91.20%
-557,000.00USD+33.32%
-417,800.00USD+57.78%
-264,800.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neximmune Stock analysis

What does Neximmune do? Neximmune Inc, trading under ticker NEXI, is a US-based biotechnology company headquartered in Gaithersburg. Founded in 2021, the company went public on February 12, 2021. It employs 50 people and operates in the Health Care sector. Neximmune focuses on developing immunotherapies using its Artificial Immune Modulation (AIM) platform, which employs nanoparticles to direct T cell responses. The company's product candidates include NEXI-001 for acute myeloid leukemia and NEXI-002 for multiple myeloma. Its AIM technology constructs synthetic dendritic cells to generate targeted immune responses. The company is clinical-stage, developing treatments for oncology and autoimmune disorders. Neximmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neximmune stock

EBIT per Employee of Neximmune is -1.26 M USD in 2022.

EBIT per Employee of Neximmune changed from -1.07 M USD to -1.26 M USD, representing a 18.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Neximmune since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Neximmune historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Neximmune

All Key Metrics — Neximmune